Pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate
C26H25F3N4O3 — CID 156781161
Data last refreshed: (MolForge compound catalog, from PubChem)
About Pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate
Pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate (PubChem CID 156781161) has the molecular formula C26H25F3N4O3 and a molecular weight of 498.51 g/mol. Its IUPAC name is pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate.
Molecular Properties
| Compound Name | Pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate |
|---|---|
| PubChem CID | 156781161 |
| Molecular Formula | C26H25F3N4O3 |
| Molecular Weight | 498.51 g/mol |
| Exact Mass | 498.19 |
| IUPAC Name | pyridin-3-ylmethyl N-[[4-[[2-pyrrolidin-1-yl-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]carbamate |
| SMILES | O=C(NCc1ccc(NC(=O)c2cc(C(F)(F)F)ccc2N2CCCC2)cc1)OCc1cccnc1 |
| InChI | InChI=1S/C26H25F3N4O3/c27-26(28,29)20-7-10-23(33-12-1-2-13-33)22(14-20)24(34)32-21-8-5-18(6-9-21)16-31-25(35)36-17-19-4-3-11-30-15-19/h3-11,14-15H,1-2,12-13,16-17H2,(H,31,35)(H,32,34) |
| InChIKey | DNAZUPBDZRMQPH-UHFFFAOYSA-N |
| XLogP | 5.38 |
| TPSA | 83.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 498.51 |
| LogP ≤ 5 | 5.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156781161 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.